ÃØÃÜÖ±²¥

APL researchers won a 2025 R&D 100 award for their nano-engineered materials called CHESS that significantly improve the efficiency of thermoelectric cooling devices. Their breakthrough nearly doubles the performance of traditional materials at room temperature, opening the way to much better cooling systems and energy-saving technologies.

A new startup, BIOPAC Medical Systems LP, has been launched to advance a novel neural blockade monitoring technology toward clinical use. The venture is a collaboration between APL, the ÃØÃÜÖ±²¥ School of Medicine, BLOCKsynop, Inc., and BIOPAC Systems, Inc., and will pursue regulatory approval and commercial deployment of a device that provides real-time, objective evaluation of regional anesthetic effectiveness.

Melissa Terlaje has been appointed chief government relations officer at APL. In this role, she will lead the Laboratory’s strategic engagements with government sponsors and stakeholders, ensuring APL’s critical contributions remain aligned with and continue to advance national priorities. Additionally, she will serve as board secretary for the Laboratory’s Board of Managers, which provides oversight of APL.

APL researchers have demonstrated that a quantum algorithm can be used to speed up an information analysis task that classical computers struggle to perform.

Revision 6.1 of the Modular Payload Design Standard, developed by a collaborative team of government and industry partners led by ÃØÃÜÖ±²¥ APL, marks a significant evolution in the way electronic warfare, signals intelligence and communications payloads are conceived, integrated and sustained across unmanned and dismounted platforms.